Clare Francis scores a bullseye: Journal of Cell Biology paper retracted for image manipulation

jcbIf you’re a journal editor or publisher, there’s a good chance your email inbox has seen its share of emails from “Clare Francis,” who has been crusading against text and image duplication in papers for some years now. Some editors have grown quite weary of those emails, sometimes because they don’t want to deal with anonymous whistleblowers, and sometimes because they have found Clare’s claims to be without merit.

But the Journal of Cellular Biology is one journal that has apparently continued to take them seriously. Today, they retract “Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion,” a 2006 paper about which Francis first raised concerns in early November. Here’s the notice, one of those wonderfully detailed ones that make us squeal like schoolgirls meeting the Beatles: Continue reading Clare Francis scores a bullseye: Journal of Cell Biology paper retracted for image manipulation

Neuroscientists retract Cell autism model paper for “improperly assembled” figures

cell 1-17-13A group of authors have retracted a Cell paper describing a mouse model of autism because of image problems.

The senior author on the paper — there were 22 altogether — is Paul Worley of Johns Hopkins. Here’s the notice for “Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism:” Continue reading Neuroscientists retract Cell autism model paper for “improperly assembled” figures

University of Lisbon investigation that spawned neuroscience retractions found no evidence of misconduct

j neuroscienceYesterday, we reported on two retractions in the Journal of Neuroscience whose notices referred to a University of Lisbon report that had determined there was  “substantial data misrepresentation” in the original articles.  The notice didn’t say anything about misconduct, but when we see “misrepresentation,” we tend to think — as do many others — that there had been funny business.

But we heard back this morning from the senior author of the study, Ana M. Sebastião, and there’s a lot more to this story. It turns out that the University of Lisbon committee that wrote the report concluded, unanimously, that Continue reading University of Lisbon investigation that spawned neuroscience retractions found no evidence of misconduct

University of Lisbon finds “substantial data misrepresentation;” two Journal of Neuroscience papers retracted

j neuroscienceA University of Lisbon investigation has prompted two retractions in the Journal of Neuroscience.

The papers share a few authors, including senior author Ana M. Sebastião. Here’s the notice for the first paper: Continue reading University of Lisbon finds “substantial data misrepresentation;” two Journal of Neuroscience papers retracted

Royal jelly figure flushed: Author removes figure from 2002 paper

j biochemRoyal jelly — “the goo that sustains honeybees destined for royalty” and is touted dubiously for everything “from youthful skin to virility,” as Nature put it — is apparently a hot research topic. So when a Retraction Watch tipster sent us a corrigendum that seemed to have done something we hadn’t seen before — retract a single figure, without saying why — we figured we’d check it out.

Here’s the text of the corrigendum: Continue reading Royal jelly figure flushed: Author removes figure from 2002 paper

First retraction for Eric Smart, who faked dozens of images, appears in PNAS

Eric J. Smart, via U Kentucky
Eric J. Smart, via U Kentucky

Eric Smart, who as we reported in November was sanctioned by the Office of Research Integrity (ORI) for faking dozens of images in ten papers and seven grants over the past decade, has had his first retraction.

Here’s the December 24 notice, from PNAS: Continue reading First retraction for Eric Smart, who faked dozens of images, appears in PNAS

Retraction three for Milena Penkowa, for diabetes-exercise study

diabetesMilena Penkowa, the former University of Copenhagen scientist found by her university to have embezzled grant funds and to have possibly committed misconduct in 15 papers, has another retraction.

An international panel released its findings in July, as Nature reported then: Continue reading Retraction three for Milena Penkowa, for diabetes-exercise study

ORI: Ohio State researcher manipulated two dozen figures in NIH grants, papers

terry elton
Terry Elton, via OSU

Terry S. Elton, a researcher at Ohio State University in Columbus who studies genetic expression in various heart conditions and Down syndrome, has been sanctioned by the U.S. Office of Research Integrity for fabricating and/or falsifying data in a number of NIH grants and resulting papers.

According to an OSU statement sent to Retraction Watch last night, it was an anonymous whistleblower who alerted the university to the potential misconduct in July 2010. The ORI report notes that he two OSU investigations, along with the ORI investigation, found that Elton: Continue reading ORI: Ohio State researcher manipulated two dozen figures in NIH grants, papers

Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation

jci1212A group of cardiology researchers formerly of the University of Cologne has retracted two papers, after investigations into allegations of misconduct led to an admission of guilt by one of the lab’s junior members.

Here’s the first retraction, for “Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes,” published last week in the Journal of Clinical Investigation: Continue reading Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation

Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Dipak Das, the resveratrol researcher found guilty of more than 100 counts of misconduct by the University of Connecticut, has two more retractions for his resume. But that’s not the most interesting part of this post, so keep reading after the notices.

Both retractions appeared in the October 2012 issue of the Journal of Cellular and Molecular Medicine. Here’s the first notice: Continue reading Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss